Sumary of Clinical trial to test whether ivermectin is effective at treating Covid set to begin:
- Clinical trials will soon begin in Minnesota to test whether or not anti-parasite drug ivermectin is effective at treating COVID-19.The University of Minnesota Medical School will be examining the drug along with two others to determine their effectiveness at combatting the virus.
- Ivermectin is approved by the U.S. Food and Drug Administration (FDA) for human use to treat certain parasite-related conditions, and it is regularly available by prescription.
- The University of Minnesota is performing a study to determine if ivermectin, fluvoxamine or metformin are effective in treating COVID-19 (file image) Ivermectin garnered attention on social media after a study found it could inhibit the replication of COVID-19 cells.
- The drug is approved by the FDA for human use to treat certain parasite-related conditions but people have overdosed using veterinary versions of the drugResearchers are currently recruiting participants for the study.
- One group will receive ivermectin alone and another will get a combination of ivermectin and metformin, a drug used to treat type 2 diabetes.
- A third group will be given metformin alone, the fourth group will receive fluvoxamine – a drug that treats obsessive compulsive disorder – and a fifth group will receive a combination of those two drugs.
- Ivermectin garnered attention of social media as a potential Covid treatment after an Australian study found the drug could inhibit replication of the virus’s cells.
- ‘In that study they showed that in cell cultures, ivermectin could inhibit [Covid] replication, but the concentrations required for that effect were in a range called the micromolar range – very high concentrations relative to what you would find in the plasma of a treated person or an animal, which would be 20 to 50 times lower,’ he said.